Revenue: The sum of all revenue fields included for a company's operating activities.
IGM Biosciences, Inc. (IGMS) had Revenue of $0.50M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$0.50M |
$-52.89M |
|
-- |
|
$0.50M |
|
$55.27M |
|
$-54.78M |
|
$1.88M |
|
$-52.89M |
|
$-52.89M |
|
$-52.89M |
|
$-52.89M |
|
$-52.89M |
|
$-52.89M |
|
$-54.78M |
|
$-52.59M |
|
61.16M |
|
61.16M |
|
$-0.86 |
|
$-0.86 |
|
| Balance Sheet Financials | |
$161.04M |
|
$16.22M |
|
$45.85M |
|
$206.89M |
|
$28.20M |
|
-- |
|
$177.99M |
|
$206.19M |
|
$0.70M |
|
$0.70M |
|
$0.70M |
|
60.06M |
|
| Cash Flow Statement Financials | |
$-32.52M |
|
$42.74M |
|
$0.01M |
|
$26.66M |
|
$36.88M |
|
$10.22M |
|
$5.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.71 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-10977.15% |
|
-10977.15% |
|
-- |
|
-10599.60% |
|
-10599.60% |
|
$-32.55M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-7577.25% |
|
-7577.51% |
|
-25.57% |
|
-7577.65% |
|
$0.01 |
|
$-0.53 |
|
$-0.53 |
|